Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Koch Hansen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Danish Medical Journal|November 6, 2014
The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitisLars Koch Hansen
Ugeskrift for Laeger|December 16, 2014
[Severe interstitial lung disease due to treatment with infliximab and azathioprine]Lars Koch Hansen, Stefano Cecere, Thøger Thøgersen
The American Journal of Emergency Medicine|November 20, 2012
Defibrillator charging before rhythm analysis significantly reduces hands-off time during resuscitation: a simulation studyLars Koch Hansen, Lars Folkestad, Mikkel Brabrand
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|January 1, 2014
Rhythm recognition is accountable for the majority of hands-off time during cardiopulmonary resuscitation - a simulation studyLars Koch Hansen, Lars K Hansen, Mikkel Brabrand
Ugeskrift for Laeger|September 10, 2013
[Atypical manifestation of infective endocarditis]Manan Pareek, Lars Koch Hansen, Dragana Rujic, et al.
Ugeskrift for Laeger|August 23, 2012
[Chronic intestinal ischaemia in a younger patient]Lars Koch Hansen, Heidi Kammerlander, Stefano Cecere, et al.
Danish Medical Journal|October 10, 2025
No post-infusion reactions after infliximab or vedolizumabLars Koch Hansen, Karina Winther Andersen, Sara Emmerich Jensen, et al.
Ugeskrift for Laeger|July 3, 2025
[Evaluation of biochemical results]Steen Antonsen, Jesper Farup Revsholm, Lars Koch Hansen, et al.
World Journal of Gastroenterology|October 4, 2017
Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseasesMorten L Halling, Jens Kjeldsen, Torben Knudsen, et al.
Plos One|April 8, 2015
High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survivalMaj Rabjerg, Aida Oliván-Viguera, Lars Koch Hansen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Danish Medical Journal|November 6, 2014
The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitisLars Koch Hansen
Ugeskrift for Laeger|December 16, 2014
[Severe interstitial lung disease due to treatment with infliximab and azathioprine]Lars Koch Hansen, Stefano Cecere, Thøger Thøgersen
The American Journal of Emergency Medicine|November 20, 2012
Defibrillator charging before rhythm analysis significantly reduces hands-off time during resuscitation: a simulation studyLars Koch Hansen, Lars Folkestad, Mikkel Brabrand
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|January 1, 2014
Rhythm recognition is accountable for the majority of hands-off time during cardiopulmonary resuscitation - a simulation studyLars Koch Hansen, Lars K Hansen, Mikkel Brabrand
Ugeskrift for Laeger|September 10, 2013
[Atypical manifestation of infective endocarditis]Manan Pareek, Lars Koch Hansen, Dragana Rujic, et al.
Ugeskrift for Laeger|August 23, 2012
[Chronic intestinal ischaemia in a younger patient]Lars Koch Hansen, Heidi Kammerlander, Stefano Cecere, et al.
Danish Medical Journal|October 10, 2025
No post-infusion reactions after infliximab or vedolizumabLars Koch Hansen, Karina Winther Andersen, Sara Emmerich Jensen, et al.
Ugeskrift for Laeger|July 3, 2025
[Evaluation of biochemical results]Steen Antonsen, Jesper Farup Revsholm, Lars Koch Hansen, et al.
World Journal of Gastroenterology|October 4, 2017
Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseasesMorten L Halling, Jens Kjeldsen, Torben Knudsen, et al.
Plos One|April 8, 2015
High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survivalMaj Rabjerg, Aida Oliván-Viguera, Lars Koch Hansen, et al.
Pageof 2